Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?

People with Cystic Fibrosis (CF), especially solid organ transplant recipients, have been prioritized in the SARS-CoV-2 vaccination program. This study assesses antibody response of patients with CF who have undergone liver (CF-LI) or lung (CF-LU) transplantation, and compares results to published d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Teresa, Appelt, Dorothea, Ellemunter, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051295/
https://www.ncbi.nlm.nih.gov/pubmed/36992241
http://dx.doi.org/10.3390/vaccines11030657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051295/
https://www.ncbi.nlm.nih.gov/pubmed/36992241
http://dx.doi.org/10.3390/vaccines11030657

Ejemplares similares